ApoER2 processing by presenilin-1 modulates reelin expression
The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
The reelin signaling protein and its downstream components have been associated with synaptic plasticity and neurotransmission. The reelin signaling pathway begins with the binding of reelin to the transmembrane lipoprotein receptor apolipopro‐tein E receptor 2 (ApoER2), which in turns induces the sequential cleavage of ApoER2 by the sequential action of α‐ and γ‐secretases. Using conditional‐knockout mice of the catalytic component of the γ‐secretase complex, presenilin 1 (PS1), we demonstrated increased brain ApoER2 and reelin protein and transcript levels, with no changes in the number of reelin‐positive cells. Using the human SH‐SY5Y neuroblastoma cell line, we showed that ApoER2 processing occurs in the presence of PS1, producing an intracellular ApoER2 C‐terminal fragment. In addition, the pharmacologic inhibition of γ‐secretase in SH‐SY5Y cells led to increased reelin levels. Overexpression of ApoER2 decreased reelin mRNA levels in these cells. A luciferase reporter gene assay and nuclear fractionation confirmed that increased amounts of intracellular fragment of ApoER2 suppressed reelin expression at a transcriptional level. Chromatin immunoprecipitation experiments corroborated that the intracellular fragment of ApoER2 bound to the RELN promoter region. Our study suggests that PS1/γ‐secretase‐dependent processing of the reelin receptor ApoER2 inhibits reelin expression and may regulate its signaling.—Balmaceda, V., Cuchillo‐Ibáñez, I., Pujadas, L., García‐Ayllón, M.‐S., Saura, C. A., Nimpf, J., Soriano, E., Sáez‐Valero, J. ApoER2 processing by presenilin‐1 modulates reelin expression. FASEB J. 28, 28–1543 (1554). www.fasebj.org
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both ApoER2 cleavage fragments are negative feedback regulators of the Reelin signal.”
From Reelin: Neurodevelopmental Architect and Homeostatic Regulator of Excitatory Synapses (2017) · cites this paper as [38]
In the citing paper
“the ApoER2-ICD can translocate to the nucleus and alter transcription of genes including inhibition of Reelin transcription (38,39).”
From Reelin: Neurodevelopmental Architect and Homeostatic Regulator of Excitatory Synapses (2017) · cites this paper as [38]
In the citing paper
“Both Reelin binding and TrkB/BDNF signaling can inhibit Reelin-mediated NMDAR phosphorylation by inducing the proteolytic processing of ApoER2 (5) (36, 47), whereby the ECD acts as a dominant negative receptor (6) (37) and the ICD can inhibit the transcription of Reelin (7) (38).”
From Reelin: Neurodevelopmental Architect and Homeostatic Regulator of Excitatory Synapses (2017) · cites this paper as [38]
Citations
Cites
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
A protein related to extracellular matrix proteins deleted in the mouse mutant reeler
D'Arcangelo, G., G. Miao, G., Chen, S.-C., Scares, H. D., Morgan, J. I., & Curran, T. (1995) · Nature · doi:10.1038/374719a0 · Cited by 1,748 · cited 1×
“Disruption of reelin, Dab1, or both ApoER2 and VLDLR leads to similar anatomic alterations during brain development, resulting in a reeler phenotype (8, 10, 11).”
BackgroundSchmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9649 · Cited by 1,525
Trommsdorff, M., Gotthardt, M., Hiesberger, T., Shelton, J., Stockinger, W., Nimpf, J., Hammer, R. E., Richardson, J. A., & Herz, J. (1999) · Cell · doi:10.1016/s0092-8674(00)80782-5 · Cited by 1,261
Self-citationNotch signaling: control of cell communication and cell fate
Lai, E. C. (2004) · Development · doi:10.1242/dev.01074 · Cited by 1,050
Hiesberger, T., Trommsdorff, M., Howell, B. W., Goffinet, A., Mumby, M. C., Cooper, J. A., & Herz, J. (1999) · Neuron · doi:10.1016/s0896-6273(00)80861-2 · Cited by 916
Reelin Is a Ligand for Lipoprotein Receptors
D'Arcangelo, G., Homayouni, R., Keshvara, L., Rice, D. S., Sheldon, M., & Curran, T. (1999) · Neuron · doi:10.1016/s0896-6273(00)80860-0 · Cited by 808
Saura, C. A., Choi, S.-Y., Beglopoulos, V., Malkani, S., Zhang, D., Rao, B. S. S., Chattarji, S., Kelleher, R. J., Kandel, E. R., Duff, K., et al. (2004) · Neuron · doi:10.1016/s0896-6273(04)00182-5 · Cited by 757 · cited 1×
“Brain cytoarchitecture, the number of neurons, and morphology were also normal (22, 23).”
BackgroundSelf-citationNeuronal position in the developing brain is regulated by mouse disabled-1
Howell, B. W., Hawkes, R., Soriano, P., & Cooper, J. A. (1997) · Nature · doi:10.1038/39607 · Cited by 692 · cited 1×
“Disruption of reelin, Dab1, or both ApoER2 and VLDLR leads to similar anatomic alterations during brain development, resulting in a reeler phenotype (8, 10, 11).”
Background
Cited by
Reelin: Neurodevelopmental Architect and Homeostatic Regulator of Excitatory Synapses
Wasser, C. R., & Herz, J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.766782 · Cited by 111
“receptor for ApoER2 ligands (37), and the ApoER2-ICD can translocate to the nucleus and alter transcription of genes including inhibition of Reelin transcription (38, 39).”
BackgroundFunctional Roles of the Interaction of APP and Lipoprotein Receptors
Pohlkamp, T., Wasser, C. R., & Herz, J. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00054 · Cited by 92
“…ECD fragment acts Frontiers in Molecular Neuroscience | www.frontiersin.org 7 March 2017 | Volume 10 | Article 54 as a dominant negative receptor (Koch et al., 2002) and the released ICD translocates to the nucleus and represses Reelin transcription (Balmaceda et al., 2014; Telese et al., 2015).”
BackgroundThe Reelin Receptors Apolipoprotein E receptor 2 (ApoER2) and VLDL Receptor
Dlugosz, P., & Nimpf, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103090 · Cited by 91
“After the second (γ-secretase dependent) cleavage, the soluble ICD is released and translocates to the nucleus and binds to the Reelin promoter, which results in the suppression of Reelin expression at a transcriptional level [58].”
BackgroundSelf-citationDifferential splicing and glycosylation of Apoer2 alters synaptic plasticity and fear learning
Wasser, C. R., Masiulis, I., Durakoglugil, M. S., Lane-Donovan, C., Xian, X., Beffert, U., Agarwala, A., Hammer, R. E., & Herz, J. (2014) · Science Signaling · doi:10.1126/scisignal.2005438 · Cited by 48
Reelin functions beyond neuronal migration: from synaptogenesis to network activity modulation
Faini, G., Bene, F. D., & Albadri, S. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.10.009 · Cited by 47
The β-amyloid peptide compromises Reelin signaling in Alzheimer’s disease
Cuchillo-Ibañez, I., Mata-Balaguer, T., Balmaceda, V., Arranz, J. J., Nimpf, J., & Sáez-Valero, J. (2016) · Scientific Reports · doi:10.1038/srep31646 · Cited by 47
Self-citationExtracellular proteolysis of reelin by tissue plasminogen activator following synaptic potentiation
Trotter, J. H., Lussier, A. L., Psilos, K. E., Mahoney, H. L., Sponaugle, A., Hoe, H., Rebeck, G. W., & Weeber, E. J. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.05.046 · Cited by 45
Passarella, D., Ciampi, S., Liberto, V. D., Zuccarini, M., Ronci, M., Medoro, A., Foderà, E., Frinchi, M., Mignogna, D., Russo, C., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168921 · Cited by 41
Acetylcholinesterase Modulates Presenilin-1 Levels and γ-Secretase Activity
Campanari, M.-L., García-Ayllón, M.-S., Belbin, O., Galcerán, J., Lleó, A., & Sáez-Valero, J. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140426 · Cited by 40
Self-citationReelin in Alzheimer’s Disease, Increased Levels but Impaired Signaling: When More is Less
Cuchillo‐Ibáñez, I., Balmaceda, V., Mata‐Balaguer, T., López‐Font, I., & Sáez‐Valero, J. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151193 · Cited by 37
Self-citationReelin‐Dab1 signaling system in human colorectal cancer
Serrano-Morales, J.-M., Vázquez‐Carretero, M. D., Rubio, M. J. P., Ilundáin, A. A., & García‐Miranda, P. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22527 · Cited by 30
Inhibition of γ-Secretase Leads to an Increase in Presenilin-1
Sogorb‐Esteve, A., García‐Ayllón, M., Llansola, M., Felipo, V., Blennow, K., & Sáez‐Valero, J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0705-1 · Cited by 30
Self-citationMata‐Balaguer, T., Cuchillo‐Ibáñez, I., Calero, M., Ferrer, I., & Sáez‐Valero, J. (2018) · The FASEB Journal · doi:10.1096/fj.201700736rr · Cited by 28
Self-citationMedoro, A., Bartollino, S., Mignogna, D., Passarella, D., Porcile, C., Pagano, A., Florio, T., Nizzari, M., Guerra, G., Marco, R. D., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170628 · Cited by 26
Carvajal, A. E., Vázquez-Carretero, M. D., García-Miranda, P., Peral, M. J., Calonge, M. L., & Ilundain, A. A. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.028 · Cited by 24
“[34] reported that ApoER2 down-regulates reelin expression in a human neuroblastoma cell line but the current study shows that DSS-treatment co-upregulates ApoER2 and reelin.”
Presenilin 1 mutations influence processing and trafficking of the ApoE receptor apoER2
Wang, W., Moerman, A., Slaton, A., & Barger, S. W. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.10.005 · Cited by 24
Reelin has antidepressant-like effects after repeated or singular peripheral injections
Allen, J., Romay-Tallón, R., Mitchell, M. A., Brymer, K. J., Johnston, J. N., Sánchez-Lafuente, C. L., Pinna, G., Kalynchuk, L. E., & Caruncho, H. J. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109043 · Cited by 22
A Lipid-Raft Theory of Alzheimer's Disease
Rappoport, A. (2024) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-052024-115455 · Cited by 20
López‐Font, I., Sogorb‐Esteve, A., Javier‐Torrent, M., Brinkmalm, G., Herrando‐Grabulosa, M., García-Lareu, B., Turón‐Sans, J., Rojas‐García, R., Lleó, A., Saura, C. A., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.12.021 · Cited by 20
Self-citationThe apolipoprotein receptor LRP3 compromises APP levels
Cuchillo‐Ibáñez, I., Lennol, M. P., Escamilla, S., Mata‐Balaguer, T., Valverde-Vozmediano, L., López‐Font, I., Ferrer, I., & Sáez‐Valero, J. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00921-5 · Cited by 16
Self-citationRIP at the Synapse and the Role of Intracellular Domains in Neurons
Lee, Y. J., & Ch’ng, T. H. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-019-08556-4 · Cited by 13
Neurotrophins regulate ApoER2 proteolysis through activation of the Trk signaling pathway
Larios, J. A., Jausoro, I., Benitez, M.-L., Bronfman, F. C., & Marzolo, M.-P. (2014) · BMC Neuroscience · doi:10.1186/1471-2202-15-108 · Cited by 12
López‐Font, I., Lennol, M. P., Iborra‐Lázaro, G., Zetterberg, H., Blennow, K., & Sáez‐Valero, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147522 · Cited by 12
Self-citationRegulation of the hippocampal translatome by Apoer2-ICD release
Wasser, C. R., Werthmann, G. C., Hall, E. M., Kuhbandner, K., Wong, C. H. Y., Durakoglugil, M. S., & Herz, J. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00652-1 · Cited by 12
Regulatory mechanism of Reelin activity: a platform for exploiting Reelin as a therapeutic agent
Hattori, M. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1546083 · Cited by 12
REELIN ameliorates Alzheimer's disease, but how?
Katsuyama, Y., & Hattori, M. (2024) · Neuroscience Research · doi:10.1016/j.neures.2024.07.004 · Cited by 9
Lin, L., Zhang, X., Cao, L., An, Q., Hao, J., Zhang, Y., Jin, R., Chang, Y., Huang, X., Lu, J., et al. (2017) · Journal of Cancer · doi:10.7150/jca.18808 · Cited by 9
Bidirectional Control between Cholesterol Shuttle and Purine Signal at the Central Nervous System
Passarella, D., Ronci, M., Liberto, V. D., Zuccarini, M., Mudò, G., Porcile, C., Frinchi, M., Iorio, P. D., Ulrich, H., & Russo, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158683 · Cited by 9
López‐Font, I., Iborra‐Lázaro, G., Sánchez‐Valle, R., Molinuevo, J. L., Cuchillo‐Ibáñez, I., & Sáez‐Valero, J. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.12.012 · Cited by 6
Self-citationOCRL1 Deficiency Affects the Intracellular Traffic of ApoER2 and Impairs Reelin-Induced Responses
Fuentealba, L. M., Pizarro, H., & Marzolo, M. (2024) · Biomolecules · doi:10.3390/biom14070799 · Cited by 5
A lipid-raft theory of Alzheimer's disease
Rappoport, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-44-345008-2.00017-5 · Cited by 2
Reelin Protects against Colon Pathology via p53 and May Be a Biomarker for Colon Cancer Progression
Serrano-Morales, J.-M., Vázquez‐Carretero, M. D., García‐Miranda, P., Carvajal, A. E., Calonge, M. L., Ilundáin, A. A., & Rubio, M. J. P. (2022) · Biology · doi:10.3390/biology11101406 · Cited by 2
Apoer2/Lrp8: the undercover cop of synaptic homeostasis
Werthmann, G. C., & Herz, J. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-02002 · Cited by 2
Reelin regulates the migration and differentiation of extravillous trophoblastic cells
Sommer, N., Alarcón-Godoy, C., Pizarro, H., Pacheco, A., Jorge Carvajal, C., Olguín, H. C., Gutiérrez, J., Leiva, A., & Marzolo, M. (2026) · Biological Research · doi:10.1186/s40659-026-00690-1 · Cited by 1
Yu, J., Cho, E., Choi, Y.-G., Jeong, Y. K., Na, Y., Kim, J., Cho, S., Woo, J., & Bae, S. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00090 · Cited by 1
Role of the Alzheimer's predisposition factor CD2AP in brain endothelial cells
Gunn, C. (2017) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/27685 · Cited by 1
ApoE Receptors, Molecular Processes, and Cellular Signaling Pathways
Jaeschke, A., & Hui, D. Y. (2025) · Springer eBooks · doi:10.1007/978-3-031-52641-1_6-1
Medoro, A., Foderà, E., Ronci, M., Trerotola, M., Mignogna, D., Raimo, G., Intrieri, M., Martino, A. D., Lepore, A., Porcile, C., et al. (2026) · BioTechniques · doi:10.1080/07366205.2026.2645347
Mignogna, D. (2021) · Archivio Istituzionale della Ricerca - Università degli Studi del Molise
Medoro, A. (2018) · Archivio Istituzionale della Ricerca - Università degli Studi del Molise
Barber, M., Andrews, W. D., Kubelka, A., Singer, H., Penna, S. L., Gavriouchkina, D., Blunskyte-Hendley, M., Becalick, A., Hao, X., Birkle, T. J. Y., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.11.12.766141
Metadata
- Authors
- Balmaceda, V., Cuchillo‐Ibáñez, I., Pujadas, L., García‐Ayllón, M., Saura, C. A., Nimpf, J., Soriano, E., & Sáez‐Valero, J.
- Affiliations
- Consejo Superior de Investigaciones Científicas (ES)
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) Madrid Spain
- Universitat Autònoma de Barcelona (ES)
- Max Perutz Labs (AT)
- Biomedical Research Networking Center on Neurodegenerative Diseases (ES)
- Corresponding author
- Sáez‐Valero, Javier
- ORCID
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2013-12-16
- Volume
- 28
- Issue
- 4
- Pages
- 1543-1554
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1990790189
- Cited by
- 40
- References
- 68
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 4 · 2023: 1 · 2022: 6 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 4 · 2017: 4 · 2016: 6 · 2014: 4
- FWCI
- 2.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Funders
- Instituto de Salud Carlos III
- Ministerio de Ciencia e Innovación (SAF2010‐20925)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- ApoER2, presenilin 1, reelin, gamma-secretase, receptor processing, transcriptional regulation, synaptic plasticity, neuroblastoma cells, conditional knockout mice
- MeSH terms
- Reelin Protein, Animals, Dipeptides, Female, Gene Expression Regulation, Humans, Luciferases, Male, Mice, Inbred C57BL, Nerve Tissue Proteins, Neuroblastoma, Promoter Regions, Genetic, Protein Binding, Serine Endopeptidases, Blotting, Western, Signal Transduction, Cell Adhesion Molecules, Neuronal, Extracellular Matrix Proteins, Mice, Knockout, Microscopy, Confocal, Reverse Transcriptase Polymerase Chain Reaction, LDL-Receptor Related Proteins, Cell Line, Tumor, Mice, Presenilin-1, Amyloid Precursor Protein Secretases, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.